Print

Eisai Company, Ltd. (ESALY.PK)'s New Breast Cancer Drug Halaven Hits UK Shores  
4/22/2011 7:21:49 AM

Pharma Times -- UK patients suffering from advanced breast cancer have gained a new treatment option after Japanese drugmaker Eisai launched its marine-based drug Halaven onto the market.
//-->